WCM Investment Management LLC Boosts Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

WCM Investment Management LLC grew its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 1.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 259,481 shares of the medical instruments supplier's stock after buying an additional 3,407 shares during the period. WCM Investment Management LLC owned 1.06% of ICU Medical worth $45,272,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in ICUI. Vanguard Group Inc. grew its stake in ICU Medical by 0.5% in the first quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier's stock valued at $263,226,000 after acquiring an additional 11,991 shares during the period. Dimensional Fund Advisors LP raised its stake in ICU Medical by 21.7% in the second quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier's stock valued at $36,996,000 after buying an additional 55,588 shares during the period. Silvercrest Asset Management Group LLC raised its stake in ICU Medical by 109.4% in the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier's stock valued at $29,882,000 after buying an additional 145,485 shares during the period. Bank of New York Mellon Corp grew its position in shares of ICU Medical by 11.5% in the second quarter. Bank of New York Mellon Corp now owns 216,509 shares of the medical instruments supplier's stock valued at $25,710,000 after purchasing an additional 22,310 shares during the last quarter. Finally, Federated Hermes Inc. grew its position in shares of ICU Medical by 9.3% in the second quarter. Federated Hermes Inc. now owns 215,808 shares of the medical instruments supplier's stock valued at $25,627,000 after purchasing an additional 18,301 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at ICU Medical

In related news, VP Daniel Woolson sold 2,502 shares of the business's stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $163.22, for a total value of $408,376.44. Following the completion of the sale, the vice president now directly owns 13,107 shares of the company's stock, valued at $2,139,324.54. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $163.46, for a total transaction of $1,961,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $17,096,771.78. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Daniel Woolson sold 2,502 shares of the business's stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $163.22, for a total value of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares in the company, valued at $2,139,324.54. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,502 shares of company stock valued at $8,445,976. Corporate insiders own 6.70% of the company's stock.

Analyst Ratings Changes

Several research firms have recently commented on ICUI. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a research report on Thursday, September 12th. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday, October 14th. They set a "hold" rating and a $183.00 price target on the stock. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research report on Thursday, October 10th. KeyCorp increased their price target on ICU Medical from $147.00 to $198.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Finally, Raymond James increased their price target on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a research report on Thursday, September 12th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $170.25.

ICU Medical Trading Up 0.8 %

ICUI traded up $1.48 during midday trading on Monday, hitting $178.27. 266,720 shares of the company were exchanged, compared to its average volume of 273,313. The firm's 50 day moving average price is $175.56 and its 200-day moving average price is $141.16. ICU Medical, Inc. has a 1-year low of $79.85 and a 1-year high of $188.53. The company has a quick ratio of 1.08, a current ratio of 2.41 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $4.35 billion, a P/E ratio of -61.05 and a beta of 0.66.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.